Amino Acids Sequence-based Analysis of Arginine Deiminase from Different Prokaryotic Organisms: An In Silico Approach

Author(s): Sara Abdollahi, Mohammad H. Morowvat*, Amir Savardashtaki, Cambyz Irajie, Sohrab Najafipour, Mahboubeh Zarei, Younes Ghasemi

Journal Name: Recent Patents on Biotechnology

Volume 14 , Issue 3 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Arginine deiminase is a bacterial enzyme, which degrades L-arginine. Some human cancers such as hepatocellular carcinoma (HCC) and melanoma are auxotrophic for arginine. Therefore, PEGylated arginine deiminase (ADI-PEG20) is a good anticancer candidate with antitumor effects. It causes local depletion of L-arginine and growth inhibition in arginineauxotrophic tumor cells. The FDA and EMA have granted orphan status to this drug. Some recently published patents have dealt with this enzyme or its PEGylated form.

Objective: Due to increasing attention to it, we aimed to evaluate and compare 30 arginine deiminase proteins from different bacterial species through in silico analysis.

Methods: The exploited analyses included the investigation of physicochemical properties, multiple sequence alignment (MSA), motif, superfamily, phylogenetic and 3D comparative analyses of arginine deiminase proteins thorough various bioinformatics tools.

Results: The most abundant amino acid in the arginine deiminase proteins is leucine (10.13%) while the least amino acid ratio is cysteine (0.98%). Multiple sequence alignment showed 47 conserved patterns between 30 arginine deiminase amino acid sequences. The results of sequence homology among 30 different groups of arginine deiminase enzymes revealed that all the studied sequences located in amidinotransferase superfamily. Based on the phylogenetic analysis, two major clusters were identified. Considering the results of various in silico studies; we selected the five best candidates for further investigations. The 3D structures of the best five arginine deiminase proteins were generated by the I-TASSER server and PyMOL. The RAMPAGE analysis revealed that 81.4%-91.4%, of the selected sequences, were located in the favored region of arginine deiminase proteins.

Conclusion: The results of this study shed light on the basic physicochemical properties of thirty major arginine deiminase sequences. The obtained data could be employed for further in vivo and clinical studies and also for developing the related therapeutic enzymes.

Keywords: Arginine deiminase, in silico, multiple sequence alignment, phylogenetic analysis, physicochemical properties, therapeutic proteins.

[1]
Schimke RT, Berlin CM, Sweeney EW, Carroll WR. The generation of energy by the arginine dihydrolase pathway in Mycoplasma hominis 07. J Biol Chem 1966; 241(10): 2228-36.
[PMID: 5911610]
[2]
Novák L, Zubáčová Z, Karnkowska A, Kolisko M, Hroudová M, Stairs CW, et al. Arginine deiminase pathway enzymes: evolutionary history in metamonads and other eukaryotes. BMC Evol Biol 2016; 16(1): 197.
[http://dx.doi.org/10.1186/s12862-016-0771-4] [PMID: 27716026]
[3]
Noens EE, Lolkema JS. Convergent evolution of the arginine deiminase pathway: the ArcD and ArcE arginine/ornithine exchangers. MicrobiologyOpen 2017; 6(1)e00412
[http://dx.doi.org/10.1002/mbo3.412] [PMID: 27804281]
[4]
Zúñiga M, Pérez G, González-Candelas F. Evolution of arginine deiminase (ADI) pathway genes. Mol Phylogenet Evol 2002; 25(3): 429-44.
[http://dx.doi.org/10.1016/S1055-7903(02)00277-4] [PMID: 12450748]
[5]
Ni Y, Schwaneberg U, Sun Z-H. Arginine deiminase, a potential anti-tumor drug. Cancer Lett 2008; 261(1): 1-11.
[http://dx.doi.org/10.1016/j.canlet.2007.11.038] [PMID: 18179862]
[6]
Takaku H, Takase M, Abe S, Hayashi H, Miyazaki K. In vivo anti-tumor activity of arginine deiminase purified from Mycoplasma arginini. Int J Cancer 1992; 51(2): 244-9.
[http://dx.doi.org/10.1002/ijc.2910510213] [PMID: 1568792]
[7]
Misawa S, Aoshima M, Takaku H, Matsumoto M, Hayashi H. High-level expression of Mycoplasma arginine deiminase in Escherichia coli and its efficient renaturation as an anti-tumor enzyme. J Biotechnol 1994; 36(2): 145-55.
[http://dx.doi.org/10.1016/0168-1656(94)90050-7] [PMID: 7765234]
[8]
Zarei M, Nezafat N, Morowvat MH, Dehshahri A, Ghoshoon MB, Berenjian A, et al. Medium optimization for recombinant soluble arginine deiminase expression in Escherichia coli using response surface methodology. Curr Pharm Biotechnol 2017; 18(11): 935-41.
[http://dx.doi.org/10.2174/1389201019666180115144752] [PMID: 29336257]
[9]
Feun L, Savaraj N. Pegylated arginine deiminase: a novel anticancer enzyme agent. Expert Opin Investig Drugs 2006; 15(7): 815-22.
[http://dx.doi.org/10.1517/13543784.15.7.815] [PMID: 16787144]
[10]
Reddy KR. Controlled-release, pegylation, liposomal formulations: new mechanisms in the delivery of injectable drugs. Ann Pharmacother 2000; 34(7-8): 915-23.
[http://dx.doi.org/10.1345/aph.10054] [PMID: 10928404]
[11]
Mehvar R. Modulation of the pharmacokinetics and pharmacodynamics of proteins by polyethylene glycol conjugation. J Pharm Pharm Sci 2000; 3(1): 125-36.
[PMID: 10954682]
[12]
Park H, Lee JB, Shim YJ, Shin YJ, Jeong S-Y, Oh J, et al. Arginine deiminase enhances MCF-7 cell radiosensitivity by inducing changes in the expression of cell cycle-related proteins. Mol Cells 2008; 25(2): 305-11.
[PMID: 18414006]
[13]
Horn F. The breakdown of arginine to citrulline by Bacillus pyocyaneus. Hoppe Seylers Z Physiol Chem 1933; 216: 244-7.
[http://dx.doi.org/10.1515/bchm2.1933.216.5-6.244]
[14]
Liu Y-M, Sun Z-H, Ni Y, Zheng P, Liu Y-P, Meng F-J. Isolation and identification of an arginine deiminase producing strain Pseudomonas plecoglossicida CGMCC2039. World J Microbiol Biotechnol 2008; 24(10): 2213-9.
[http://dx.doi.org/10.1007/s11274-008-9732-4]
[15]
Galkin A, Kulakova L, Sarikaya E, Lim K, Howard A, Herzberg O. Structural insight into arginine degradation by arginine deiminase, an antibacterial and parasite drug target. J Biol Chem 2004; 279(14): 14001-8.
[http://dx.doi.org/10.1074/jbc.M313410200] [PMID: 14701825]
[16]
Lu X, Li L, Wu R, Feng X, Li Z, Yang H, et al. Kinetic analysis of Pseudomonas aeruginosa arginine deiminase mutants and alternate substrates provides insight into structural determinants of function. Biochemistry 2006; 45(4): 1162-72.
[http://dx.doi.org/10.1021/bi051591e] [PMID: 16430212]
[17]
Miyazaki K, Takaku H, Umeda M, Fujita T, Huang W, Kimura T, et al. Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of a Mycoplasma-infected cell line. Cancer Res 1990; 50(15): 4522-7.
[PMID: 2164440]
[18]
Takaku H, Matsumoto M, Misawa S, Miyazaki K. Anti-tumor activity of arginine deiminase from Mycoplasma argini and its growth-inhibitory mechanism. Jpn J Cancer Res 1995; 86(9): 840-6.
[http://dx.doi.org/10.1111/j.1349-7006.1995.tb03094.x] [PMID: 7591961]
[19]
Kim J-E, Jeong D-W, Lee HJ. Expression, purification, and characterization of arginine deiminase from Lactococcus lactis ssp. lactis ATCC 7962 in Escherichia coli BL21. Protein Expr Purif 2007; 53(1): 9-15.
[http://dx.doi.org/10.1016/j.pep.2006.12.002] [PMID: 17223359]
[20]
Burne RA, Parsons DT, Marquis RE. Cloning and expression in Escherichia coli of the genes of the arginine deiminase system of Streptococcus sanguis NCTC 10904. Infect Immun 1989; 57(11): 3540-8.
[http://dx.doi.org/10.1128/IAI.57.11.3540-3548.1989] [PMID: 2530176]
[21]
Monstadt GM, Holldorf AW. Arginine deiminase from Halobacterium salinarium. Purification and properties. Biochem J 1991; 273(Pt 3): 739-45.
[http://dx.doi.org/10.1042/bj2730739] [PMID: 1847623]
[22]
Gasteiger E, Hoogland C, Gattiker A, Wilkins MR, Appel RD, Bairoch A. Protein identification and analysis tools on the ExPASy server.In: Walker JM, Ed. The proteomics protocols handbook. Berlin: Springer 2005; pp. 571-607.
[http://dx.doi.org/10.1385/1-59259-890-0:571]
[23]
Bailey TL, Elkan C. Unsupervised learning of multiple motifs in biopolymers using expectation maximization. Mach Learn 1995; 21(1): 51-80.
[http://dx.doi.org/10.1007/BF00993379]
[24]
Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol 2016; 33(7): 1870-4.
[http://dx.doi.org/10.1093/molbev/msw054] [PMID: 27004904]
[25]
Grasso EJ, Sottile AE, Coronel CE. Structural prediction and in silico physicochemcial characterization for mouse caltrin I and bovine caltrin proteins. Bioinform Biol Insights 2016; 10: 225-36.
[http://dx.doi.org/10.4137/BBI.S38191] [PMID: 27812283]
[26]
Vidhya VG, Swarnalatha Y, Bhaskar A. An in silico analysis of physicochemcial characterization and protein-protein interaction network analysis of human anti-apoptotoic proteins. Asian J Pharm 2018; 12(4): S1397-407.
[27]
Zadeh Hosseingholi E, Neghabi N, Molavi G, Gheibi Hayat SM, Shahriarpour H. In silico identification and characterization of antineoplastic asparaginase enzyme from endophytic bacteria. IUBMB Life 2020; 11: 1-10.
[http://dx.doi.org/10.1002/iub.2237] [PMID: 31981306]
[28]
Ikai A. Thermostability and aliphatic index of globular proteins. J Biochem 1980; 88(6): 1895-8.
[PMID: 7462208]
[29]
Guruprasad K, Reddy BV, Pandit MW. Correlation between stability of a protein and its dipeptide composition: a novel approach for predicting in vivo stability of a protein from its primary sequence. Protein Eng 1990; 4(2): 155-61.
[http://dx.doi.org/10.1093/protein/4.2.155] [PMID: 2075190]
[30]
D’Hooghe I, Vander Wauven C, Michiels J, Tricot C, de Wilde P, Vanderleyden J, et al. The arginine deiminase pathway in Rhizobium etli: DNA sequence analysis and functional study of the arcABC genes. J Bacteriol 1997; 179(23): 7403-9.
[http://dx.doi.org/10.1128/JB.179.23.7403-7409.1997] [PMID: 9393705]
[31]
Lovell SC, Davis IW, Arendall WB, De Bakker PI, Word JM, Prisant MG, et al. Structure validation by Cα geometry: ϕ, ψ and Cβ deviation. Proteins: struct. Funct Bioinf 2003; 50(3): 437-50.
[32]
Bomalaski J, Wu B-W. Methods of treatment with arginine deiminase. WO 151568A1 2013.
[33]
Ensor CM, Holtsberg FW, Clark MA. Mutated form of arginine deiminase. EP 1278868B9 2008.
[34]
Xiaoyu F, Jianqun L, Yushuan S, Xiaofang W, Yefei W, Yuzhang W, et al. Arginine deiminase mutant and preparation and application therof. CN 101812438A 2010.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 14
ISSUE: 3
Year: 2020
Published on: 25 September, 2020
Page: [235 - 246]
Pages: 12
DOI: 10.2174/1872208314666200324114441
Price: $65

Article Metrics

PDF: 12
HTML: 2
EPUB: 1
PRC: 1